Pantoprazolo Zentiva Italia (Pantoprazole Sodium Sesquihydrate)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders.

• Gastro‑esophageal reflux disease (GERD): improves heartburn and esophageal irritation by reducing acid exposure.
• Erosive esophagitis: promotes healing of erosive lesions in the esophagus.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑producing tumors.

• Pantoprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, blocking the final step of acid production. This inhibition markedly lowers both basal and stimulated gastric acidity, allowing the gastrointestinal mucosa to heal and reducing reflux‑related symptoms.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional upset stomach.
• Abdominal pain: mild cramping.
• Flatulence: increased gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels: muscle cramps, irregular heartbeat.
• Liver enzyme elevation: abnormal liver function tests.
• Acute interstitial nephritis: kidney inflammation.
• Fracture risk with long‑term use: decreased bone density.

Before initiating therapy, consider patient‑specific factors and monitor for potential complications.

• Renal impairment: adjust use if severe kidney disease is present.
• Hepatic impairment: use with caution in moderate to severe liver disease.
• Elderly patients: monitor for dehydration and electrolyte disturbances.
• Concomitant medications: review for drugs that may affect gastric pH or absorption.
• Pregnancy and lactation: evaluate risk‑benefit ratio with a prescriber.
• Store at ambient temperature: keep below 25°C, retain original packaging, and protect from moisture.

Pantoprazole may alter the absorption or metabolism of several co‑administered drugs.

Major Interactions (Avoid)

• Antiretroviral protease inhibitors (e.g., atazanavir): reduced efficacy due to increased gastric pH.
• Antifungal agents (e.g., ketoconazole, itraconazole): markedly decreased absorption.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation.
• Methotrexate: reduced renal clearance; watch for toxicity.
• Digoxin: slight increase in serum levels; assess clinical response.